Blanca M, Vega J M, Garcia J, Carmona M J, Terados S, Avila M J, Miranda A, Juarez C
Internal Medicine Department, Carlos Haya Hospital, Malaga, Spain.
Clin Exp Allergy. 1990 Sep;20(5):475-81. doi: 10.1111/j.1365-2222.1990.tb03139.x.
Two hundred and eighty-eight subjects with a history of allergy to penicillin were studied for objective proof of their allergy. On the basis of skin tests, specific IgE antibody measurements and direct challenge tests. 64 patients (22%) were shown objectively to be allergic to one or more penicillins. The following tests were carried out: skin tests to benzyl-penicilloyl poly-L-lysine (BPO-PLL), minor determinant mixture (MDM), amoxycillin (AX) and ampicillin (AMP), in-vitro IgE antibody measurement to benzyl-penicilloyl (BPO) and AX and challenge with benzylpenicillin (BP), phenoxy-methyl-penicillin (PV) and amoxycillin. Forty-four cases were found to respond to benzyl or phenoxymethyl-penicillin, however, 20 were shown to be sensitive to amoxycillin and unresponsive to tests with other penicillins. The contribution that any individual test gave for establishing the diagnosis was 21.8% for skin testing with BPO-PLL, 9.3% with MDM and 12.5% with AX. Nine point three per cent were RAST positive to BPO and 1.5% to AX; 7.8% developed a positive response after challenge to BP, 7.8% to PV and 14% to AX. In 16% of the 64 positive cases more than one test was found to be positive. The challenge tests suggested that not all the penicillin-sensitive subjects had IgE-mediated reactions implying other immunological mechanisms. These results clearly demonstrate the importance of side chain-specific diagnostic reagents and challenge tests. Thirty-one per cent of the positive group or 6.9% of the total group would have been missed in this study using benzyl or phenoxymethyl-penicillin diagnostic reagents alone.
对288名有青霉素过敏史的受试者进行了过敏客观证据的研究。基于皮肤试验、特异性IgE抗体检测和直接激发试验。结果显示,64名患者(22%)被客观证实对一种或多种青霉素过敏。进行了以下检测:对苄青霉素酰聚-L-赖氨酸(BPO-PLL)、次要决定簇混合物(MDM)、阿莫西林(AX)和氨苄西林(AMP)进行皮肤试验,对苄青霉素酰(BPO)和AX进行体外IgE抗体检测,并用苄青霉素(BP)、苯氧甲基青霉素(PV)和阿莫西林进行激发试验。发现44例对苄青霉素或苯氧甲基青霉素有反应,然而,20例对阿莫西林敏感,对其他青霉素检测无反应。对于确诊而言,任何一项单独检测的贡献分别为:用BPO-PLL进行皮肤试验为21.8%,用MDM为9.3%,用AX为12.5%。9.3%的患者对BPO的放射性过敏原吸附试验(RAST)呈阳性,对AX呈阳性的为1.5%;7.8%的患者在接受BP激发试验后呈阳性反应,7.8%对PV呈阳性,14%对AX呈阳性。在64例阳性病例中,16%的病例发现不止一项检测呈阳性。激发试验表明,并非所有对青霉素敏感的受试者都有IgE介导的反应,这意味着存在其他免疫机制。这些结果清楚地证明了侧链特异性诊断试剂和激发试验的重要性。在本研究中,仅使用苄青霉素或苯氧甲基青霉素诊断试剂会遗漏31%的阳性组患者或6.9%的全部患者。